November 2011 | Oncology & Biotech News

January 04, 2012

Parents prefer palliative chemotherapy for their child with cancer who is not expected to survive, while healthcare workers favor supportive care.

January 04, 2012

Chemotherapy given at the same time as radiotherapy may be a feasible treatment for high-risk nonmelanoma skin cancer (NMSC) of the head and neck.

December 20, 2011

Some cosmetologists and barbers inspect their customers' scalps, necks, and faces for the presence of skin lesions that they think may be cancerous.

December 20, 2011

Researchers are urging oncologists to improve the communication of complex medical information to their patients.

December 20, 2011

The rate of hospitalization in older men within 30 days of a prostate biopsy is more than double that occurring in a control population not undergoing a biopsy.

December 19, 2011

New data show that patients treated for lung cancer at high safety-net burden hospitals undergo curative-intent surgery significantly less often than individuals treated at low safety-net burden facilities.

December 19, 2011

Bone disease occurs in about 84% of patients with multiple myeloma and is responsible for a great deal of morbidity, including pain, hypercalcemia, compromised quality of life, and pathological fracture.

December 16, 2011

A single dose of radiotherapy and a single injection of ibandronate provided similar pain relief from bone metastases in men with metastatic prostate cancer.

December 16, 2011

Physicians and patients with castration-resistant prostate cancer (CRPC) have an increasing number of treatment options that improve outcomes.

December 15, 2011

A subanalysis of the AZURE study found that postmenopausal women had a disease-free survival advantage from the addition of zoledronic acid to their therapy.

December 14, 2011

Maintenance therapy with bevacizumab plus pemetrexed achieved a 4-month benefit in progression-free survival (PFS) versus bevacizumab maintenance therapy alone.

December 14, 2011

Cancer treatment is moving from a one-size-fits-all approach to personalized medicine, which means matching the right drug with the right tumor characteristics.

December 12, 2011

New data support a potential link between early-onset androgenic alopecia and the development of prostate cancer.

December 08, 2011

After decades of use, a routine test used for diagnosing prostate cancer has come under fire after a government panel questioned its safety.

December 06, 2011

Established in 1973 as the University of Pennsylvania's Cancer Center and subsequently renamed in 2002, the Abramson Cancer Center is a world leader in research, patient care, and education.

December 06, 2011

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Oncology Meeting.

December 05, 2011

A look at tweaking the corruptive influence of the virus information code to selectively corrupt cancer cells while sparing (normal) cells that do not have a specific cancer phenotype.